Inventor

MONTGOMERY ALAN BRUCE

US26 patents

⚠️ This page may combine multiple inventors who share the name “MONTGOMERY ALAN BRUCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MONTGOMERY ALAN BRUCE

GILEAD SCIENCES INC

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks

Method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacks

Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

Method for improvement of tolerance for therapeutically effective agents delivered by inhalation

CARDEAS PHARMA CORP

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties

MONTGOMERY ALAN BRUCE

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

CARDEAS PHARMA INC

Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

CORUS PHARMA INC

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections

Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate

PATHOGENESIS CORP

Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis

Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

SALUS PHARMA INC

Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections

SAVARA INC

Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties